This pathology segment provides a detailed microscopic overview of Fibrous Hamartoma of Infancy (FHI), a benign lesion typically presenting in young children. FHI is defined by a characteristic "quilt-like" histologic pattern that includes a diagnostic triad: mature adipose tissue, bland fibroblast fascicles, and nodular clusters of immature mesenchyme. The lecture stresses the importance of differentiating FHI from Dermatofibrosarcoma Protuberans (DFSP), as both can exhibit fat entrapment. Distinguishing features and diagnostic strategies are discussed, including the high-power recognition of FHI's hypocellular fascicles and the strategic use of immunohistochemistry (S100/SOX10) and molecular testing (FISH for COL1A1-PDGFB translocation) to definitively rule out DFSP in ambiguous, CD34-positive spindle cell lesions.
Summarizing Fibrous Hamartoma of Infancy (FHI)
0:05 FHI Clinical Presentation and Low Power: FHI is typically found in infants (e.g., 6-month-old) as a skin-colored nodule (often near the axilla). At low power, the lesion displays a very haphazard, patchy, "quilt-like" pattern combining fibrous material, cellularity, and fat, crucially lacking a central dominant mass.
0:36 The Fascicular Component: FHI contains areas of bland fibroblasts forming nice fascicles with wavy, dense collagen. The speaker clarifies that waviness in spindle cells combined with collagen is typically indicative of fibroblasts, not nerves (a common misconception).
1:00 The Diagnostic Triad: FHI is identified by the simultaneous presence of three components: (1) Mature fat, (2) Fibroblasts forming fascicles, and (3) Clusters of immature mesenchyme (spindle to stellate or round, uniform cells, often with a myxoid background).
1:29 The DFSP Pitfall: It is vital to recognize FHI as benign and distinguish it from Dermatofibrosarcoma Protuberans (DFSP). FHI can exhibit "honeycomb-like fat entrapment," which may incorrectly lead a pathologist to consider the diagnosis of DFSP.
2:01 Histological Clues for Benignity: Unlike most DFSP (which is storiform), FHI often features well-formed, hypocellular fascicles. The presence of these parallel fascicles is reassuring for benign entities like FHI, CD34 positive fibroblastic connective tissue nevus, or dermatomyofibroma.
3:34 IHC Differentiation (S100/SOX10): Since FHI, DFSP, and neurofibroma can all be CD34 positive, S100 or SOX10 should be used to distinguish between DFSP and diffuse neurofibroma. DFSP is extremely rarely positive for S100 or SOX10.
4:14 Molecular Testing (FISH): If uncertainty persists, the gold standard is FISH for the COL1A1-PDGFB translocation, which confirms DFSP.
4:27 Strategic Rationale for FISH: The lecturer primarily uses FISH when they suspect the lesion is not DFSP (i.e., when faced with a small, bland, CD34 positive biopsy) to gain a definitive benign diagnosis quickly, avoiding delayed care or an unnecessary major surgical procedure.